Preventive imager laments fall of EBCT, spreads the blame

Article

"Few radiologists understand preventive cardiology. They are enamored with less noisy pictures, and that's it. And few traditionally trained cardiologists care about coronary prevention and risk stratification of the asymptomatic person. Prevention falls to the primary-care doctor who, sadly, witnesses the specialists' apathy.

"Few radiologists understand preventive cardiology. They are enamored with less noisy pictures, and that's it. And few traditionally trained cardiologists care about coronary prevention and risk stratification of the asymptomatic person. Prevention falls to the primary-care doctor who, sadly, witnesses the specialists' apathy.

"As a result, EBCT coronary calcium imaging, with its low reimbursement, has not been a growth industry. The MSCT angiogram, however, has animated both radiologists and cardiologists. My centers have been doing CT angios since 1999 (when it was FDA approved with the EBCT scanner), and yet the average doctor thinks this is a new field.

"The decline in interest in EBCT imaging is all about money for the manufacturers. If they can sell hundreds of MSCT scanners to radiology groups who need them for all of their CT services, is it worth maintaining a sales force for the very few cardiac hospitals or cardiology groups who really care about accuracy and clinical validation and would opt for an EBCT scanner?

"Let's not delude ourselves into thinking that the failure of an EBCT model has to do with superiority of the MSCT scanners. The real issue is that MSCT is just a better market for the manufacturers."

-Dr. James Ehrlich, president of the Society for Responsible Preventive Imaging and medical director of Colorado Heart and Body Imaging.

Recent Videos
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Nina Kottler, MD, MS
Related Content
© 2025 MJH Life Sciences

All rights reserved.